TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35710395

Group type: EXPERIMENTAL
Intervention: Exercise training with post-exercise sauna treatments (ET + S, n = 8)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Exercise training without sauna treatments (ET, n = 7)
Number of subjects: 15
Study: 34321144

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA, NuSmile® NeoMTA®)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ferric Sulfate (FS)
Number of subjects: 50
Study: 33213400

Group type: EXPERIMENTAL
Intervention: Guided self-help ACT-training
Number of subjects: 290

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Maternal hair cortisol concentrations
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Qualitative interviews
Number of subjects: 290
Study: 35324342

Group type: EXPERIMENTAL
Intervention: Surgical intervention (N = 166)
Number of subjects: 341

Group type: COMPARATOR
Intervention: No surgical intervention (N = 175)
Number of subjects: 341
Study: 35598636

Group type: EXPERIMENTAL
Intervention: Multi-component edetate disodium (Na2EDTA)‐based chelation solution, 40 weekly infusions
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Twice daily oral, high-dose multivitamin and mineral supplements
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo (control group for chelation therapy)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo (control group for multivitamin and mineral supplements)
Number of subjects: 1000
Study: 33570248

Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33264811

Group type: EXPERIMENTAL
Intervention: Cold Snare Polypectomy (CSP)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Hot Snare Polypectomy (HSP)
Number of subjects: 496
Study: 33832572

Group type: EXPERIMENTAL
Intervention: Impact 754 ventilator
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Impact 731 ventilator
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Hamilton‐T1 ventilator
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: SAVe II ventilator
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: All ventilators tested
Number of subjects: 4
Study: 32618115

Group type: EXPERIMENTAL
Intervention: COMBIND intervention (specialized behavioural training plus a tablet-based mHealth application)
Number of subjects: 1191

Group type: COMPARATOR
Intervention: Standard-of-care (SOC) ORW training
Number of subjects: 1191
Study: 34180370

Group type: EXPERIMENTAL
Intervention: Adherence strategies delivered over five sessions
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard hospital care and home exercise program (Control)
Number of subjects: 52
Study: 33814435

Group type: EXPERIMENTAL
Intervention: Baseline anemia (anemiav1)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Baseline RDW (RDWv1)
Number of subjects: 213
Study: 36028775

Group type: EXPERIMENTAL
Intervention: Individual nutrition therapy (five in person visits and three phone calls) and freely delivered energy- and protein-rich foods
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Individual nutrition therapy
Number of subjects: 106
Study: 33651970

Group type: EXPERIMENTAL
Intervention: Interprofessional Training Ward MIA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study: 32812964

Group type: EXPERIMENTAL
Intervention: AOB‐w (350 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 34018342

Group type: EXPERIMENTAL
Intervention: Luvadaxistat 75 mg BID
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Luvadaxistat 300 mg BID
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 34863136

Group type: EXPERIMENTAL
Intervention: Multiple Health Behaviour Change (MHBC) intervention
Number of subjects: 3062

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 3062
Study: 35427363

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (3000 IU daily)
Number of subjects: 2300

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 2300

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 2300
Study: 34090495

Group type: EXPERIMENTAL
Intervention: Online events for sharing trial results
Number of subjects: 0
Study: 34704877

Group type: EXPERIMENTAL
Intervention: Vitamin D2 40,000 IU/week
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34189336

Group type: EXPERIMENTAL
Intervention: Caffeine-free alternatives
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Caffeine-free and sugar-free alternatives
Number of subjects: 29

Group type: COMPARATOR
Intervention: Caffeinated sugary drinks (control)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 29
Study: 35361380

Group type: EXPERIMENTAL
Intervention: DHEA supplementation (n = 18)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No DHEA supplementation (n = 20)
Number of subjects: 60
Study: 32089148

Group type: EXPERIMENTAL
Intervention: Brief Intervention to Promote Service Engagement (BIPSE)
Number of subjects: 0
Study: 34985973

Group type: EXPERIMENTAL
Intervention: 15 to 30 mg of arbaclofen (GABAB receptor agonist)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 33887429

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided regional anesthesia (US‐RA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 78
Study: 33198286

Group type: EXPERIMENTAL
Intervention: Group citizenship behavior with high environmental dynamism
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Group citizenship behavior with low environmental dynamism
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Interaction of group citizenship behavior and environmental dynamism
Number of subjects: 339
Study: 35870425

Group type: EXPERIMENTAL
Intervention: Office hysteroscopy with endometrial scratch
Number of subjects: 0

Group type: COMPARATOR
Intervention: Office hysteroscopy
Number of subjects: 0
Study: 34160294

Group type: EXPERIMENTAL
Intervention: Kinect‐TOLF
Number of subjects: 30
Study: 32764951

Group type: EXPERIMENTAL
Intervention: CAVI above the predicted value
Number of subjects: 163

Group type: COMPARATOR
Intervention: CAVI predicted values by age and sex
Number of subjects: 163
Study: 36149118

Group type: EXPERIMENTAL
Intervention: Semi-fowler's position
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 450
Study: 33041200

Group type: EXPERIMENTAL
Intervention: Pharmacist phone call intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No pharmacist phone call intervention (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost of the first dose to the patient
Number of subjects: 0
Study: 33559294

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750mg once daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ciprofloxacin 400mg twice daily
Number of subjects: 200
Study: 36200143

Group type: EXPERIMENTAL
Intervention: BlockBuster group (n = 351)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Supreme group (n = 300)
Number of subjects: 651
Study: 33550515

Group type: EXPERIMENTAL
Intervention: 2 min/bed position (bp) acquisition
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 1 min/bed position (bp) acquisition
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 30 s/bed position (bp) acquisition
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All acquisition times
Number of subjects: 21
Study: 32203684

Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 303
Study: 34524953

Group type: EXPERIMENTAL
Intervention: Rescue intervention strategy (RIS) with budesonide/formoterol plus original treatment until severe pollution ended
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group maintained on original treatment
Number of subjects: 22
Study: 32138842

Group type: EXPERIMENTAL
Intervention: Antimicrobial neutrophil extract (ANE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Osteochondral implantation
Number of subjects: 0
Study: 35820804

Group type: EXPERIMENTAL
Intervention: QLB (quadratus lumborum block)
Number of subjects: 80

Group type: COMPARATOR
Intervention: NS (normal saline)
Number of subjects: 80
Study: 33683822

Group type: EXPERIMENTAL
Intervention: Genomic offsets derived from Gradient Forests (GF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Candidate SNPs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naive climate transfer distances
Number of subjects: 0
Study: 33003338

Group type: EXPERIMENTAL
Intervention: Functional Food Breakfast (FB)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control Breakfast (CB)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ready-to-eat Breakfast Cereal (RTEC)
Number of subjects: 16
Study: 35877016

Group type: EXPERIMENTAL
Intervention: Nursing process based on King’s Theory of Goal Attainment (TGA) implemented for 1 month.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 70
Study: 33927112

Group type: EXPERIMENTAL
Intervention: Traditional-set structure (TRAD, n = 10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Cluster-set structure (CLUS, n = 11)
Number of subjects: 21
Study: 33573681

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine 2% (20mg/mL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous NaCl 0.9% (9 mg/mL)
Number of subjects: 100
Study: 35165105

Group type: EXPERIMENTAL
Intervention: Incentivised-peer-networks distributing HIVST packs with HIV prevention information
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Direct distribution of HIVST packs by peer navigators
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard-of-care peer navigators distributing information without HIVST kits
Number of subjects: 45
Study: 34635372

Group type: EXPERIMENTAL
Intervention: 3D Delta Plate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional miniplates
Number of subjects: 20
Study: 34208986

Group type: EXPERIMENTAL
Intervention: High protein snack (HP), n = 52, containing 50 g soybean
Number of subjects: 107

Group type: COMPARATOR
Intervention: Isocaloric low-protein snack (LP), n = 55
Number of subjects: 107
Study: 32661522

Group type: EXPERIMENTAL
Intervention: DFDBA after intramarrow penetration along with open flap debridement (OFD+IMP+ DFDBA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: DFDBA along with open flap debridement (OFD+DFDBA)
Number of subjects: 40
Study: 33152169

Group type: EXPERIMENTAL
Intervention: Suture stent
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard ureteric stent
Number of subjects: 88
Study: 32591594

Group type: EXPERIMENTAL
Intervention: Standard care plus cold atmospheric plasma (SC + CAP)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasma (CAP)
Number of subjects: 44
Study: 36273182

Group type: EXPERIMENTAL
Intervention: Culturally secure intervention involving training in culturally safe care and enhanced support from Aboriginal Brain Injury Coordinators.
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control phase (no intervention).
Number of subjects: 108
Study: 32618244

Group type: EXPERIMENTAL
Intervention: 0.05% deltamethrin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.1% bendiocarb
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.25% pirimiphos‐methyl
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4% DDT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Piperonyl butoxide (PBO) pre-exposure
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Overall sporozoite infection rate
Number of subjects: 20
Study: 35597993

Group type: EXPERIMENTAL
Intervention: AMS ENGAGEMENT bundle (multimodal multi-disciplinary interventions including education for nurses and general practitioners, telehealth support, and formation of an antimicrobial stewardship team)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual care processes for antibiotic use and stewardship (control group)
Number of subjects: 18
Study: 33524515

Group type: EXPERIMENTAL
Intervention: ODRA plus usual care (ODRA group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care alone (UCA group)
Number of subjects: 120
Study: 33958501

Group type: EXPERIMENTAL
Intervention: Placebo 'energy drink' (deliberate positive information)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Regular water (standard information)
Number of subjects: 17
Study: 32311627

Group type: EXPERIMENTAL
Intervention: Balloon catheter (outpatient)
Number of subjects: 695
Study: 34323589

Group type: EXPERIMENTAL
Intervention: 0.1 mmol/kg gadoteridol at a rate of 3 mL/s (group A)
Number of subjects: 85

Group type: COMPARATOR
Intervention: 0.1 mmol/kg gadoteridol at a rate of 2 mL/s (group B)
Number of subjects: 85
Study: 34666875

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting distant metastasis risk based on independent risk factors.
Number of subjects: 411
Study: 32359021

Group type: EXPERIMENTAL
Intervention: Novel yeast extract
Number of subjects: 60

Group type: COMPARATOR
Intervention: Colloidal oatmeal lotion (Aveeno™ Eczema Therapy Moisturizing Cream)
Number of subjects: 60
Study: 33067295

Group type: EXPERIMENTAL
Intervention: Internet-based patient-primary care physician-cardiologist integrated management model of hypertension (RSCDMS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional care group
Number of subjects: 0
Study: 36079816

Group type: EXPERIMENTAL
Intervention: 5‐day fasting followed by 10 weeks of lifestyle modification (F + LM; n = 73)
Number of subjects: 145

Group type: COMPARATOR
Intervention: 10 weeks of lifestyle modification only (LM; n = 72)
Number of subjects: 145
Study: 33208263

Group type: EXPERIMENTAL
Intervention: PEEK‐A (Ar cold plasma treatment)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: PEEK‐N (N2 cold plasma treatment)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: PEEK‐AN (90% Ar and 10% N2 mixed cold plasma treatment)
Number of subjects: 4

Group type: COMPARATOR
Intervention: PEEK‐C (untreated)
Number of subjects: 4
Study: 32139455

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 309
Study: 35720377

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (n = 30)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 59
Study: 35949401

Group type: EXPERIMENTAL
Intervention: Care navigation intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 46
Study: 32969489

Group type: EXPERIMENTAL
Intervention: Dupilumab 2 mg kg−1
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Dupilumab 4 mg kg−1
Number of subjects: 38
Study: 32645163

Group type: EXPERIMENTAL
Intervention: Physical function impairment (Short Physical Performance Battery score ≤10)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Frailty
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Prefrailty
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Older age, black race, greater BMI, and physical inactivity
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Depression and hypertension
Number of subjects: 266
Study: 34980467

Group type: EXPERIMENTAL
Intervention: Fundoplication without esophagocrural sutures
Number of subjects: 106

Group type: COMPARATOR
Intervention: Fundoplication with esophagocrural sutures
Number of subjects: 106
Study: 34268630

Group type: EXPERIMENTAL
Intervention: Single-crown restorations supported by short implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard length implants in conjunction with maxillary sinus floor augmentation (MSFA)
Number of subjects: 40
Study: 32891918

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Low working memory capacity
Number of subjects: 138
Study: 34391724

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 33941638

Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids and nebulised epinephrine for bronchiolitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32519824

Group type: EXPERIMENTAL
Intervention: Modern/interactive nutrition education methods
Number of subjects: 170

Group type: COMPARATOR
Intervention: Traditional/informative nutrition education methods (Control)
Number of subjects: 170
Study: 34154557

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Knowledge of FA
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Demographic factors associated with FA knowledge
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Factors affecting FA intake before pregnancy
Number of subjects: 428
Study: 36217068

Group type: EXPERIMENTAL
Intervention: Combination therapy (adding an anti‐staphylococcal beta‐lactam)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard therapy (vancomycin monotherapy)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: (Flu)cloxacillin as the companion beta‐lactam
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Vancomycin area under the concentration–time curve
Number of subjects: 266
Study: 34111095

Group type: EXPERIMENTAL
Intervention: Exer-gaming group (EGG) (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional training (TBT) group (n=15)
Number of subjects: 30
Study: 32674956

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 54
Study: 34958364

Group type: EXPERIMENTAL
Intervention: Behavioral intervention with free meat substitutes for 4 weeks, information about benefits of eating less meat, success stories, and recipes.
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group received no intervention or advice on dietary change.
Number of subjects: 115
Study: 33028054

Group type: COMPARATOR
Intervention: SRP plus PVP-I 0.1% irrigant
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SRP plus BA 0.5% irrigant
Number of subjects: 36
Study: 32168290

Group type: EXPERIMENTAL
Intervention: Tablet-based Decision Support Tool (DST)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Memory alone
Number of subjects: 109
Study: 34817445

Group type: EXPERIMENTAL
Intervention: Active 5 Hz‐rTMS
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 8
Study: 34024532

Group type: EXPERIMENTAL
Intervention: Moderate Energy Restriction (MER)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Severe Energy Restriction (SER)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Carbohydrate refeed after Severe Energy Restriction
Number of subjects: 11
Study: 32429977

Group type: EXPERIMENTAL
Intervention: Oxytocin vaginal gel (400 IU per night)
Number of subjects: 96
Study: 36167610

Group type: EXPERIMENTAL
Intervention: MINST + PACNs
Number of subjects: 46

Group type: COMPARATOR
Intervention: MINST
Number of subjects: 46
Study: 34671971

Group type: EXPERIMENTAL
Intervention: Early cryoprecipitate transfusion (two pools within 90 minutes of first red blood cell unit requested plus standard care)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard care (cryoprecipitate administered later or not at all)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Early cryoprecipitate transfusion
Number of subjects: 180
Study: 34022880

Group type: EXPERIMENTAL
Intervention: Individualized surgery combined with radiotherapy and triamcinolone acetonide injection
Number of subjects: 67
Study: 32163845

Group type: EXPERIMENTAL
Intervention: ePED iPad application
Number of subjects: 395

Group type: COMPARATOR
Intervention: Usual discharge teaching (Control)
Number of subjects: 395
Study: 34634368

Group type: EXPERIMENTAL
Intervention: Combination group (FSGTC plus imrecoxib)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: FSGTC group (FSGTC plus imrecoxib placebo)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Imrecoxib group (imrecoxib plus FSGTC placebo)
Number of subjects: 180
Study: 33215562

Group type: EXPERIMENTAL
Intervention: Glasdegib plus low-dose cytarabine (LDAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose cytarabine (LDAC) alone
Number of subjects: 0
Study: 33176210

Group type: EXPERIMENTAL
Intervention: Initial invasive strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Initial conservative approach
Number of subjects: 0
Study: 32053110

Group type: EXPERIMENTAL
Intervention: Highly purified cannabidiol (CBD) (Epidiolex®)
Number of subjects: 4
Study: 33771819

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 708

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 708
Study: 33877325

Group type: EXPERIMENTAL
Intervention: MWM
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: MWMtape
Number of subjects: 45

Group type: COMPARATOR
Intervention: MOB
Number of subjects: 45
Study: 35325085

Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 6774

Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 6774
Study: 33001140

Group type: EXPERIMENTAL
Intervention: 4 mg of baricitinib once daily (n=111)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: 2 mg of baricitinib once daily (n=109)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Placebo (n=109)
Number of subjects: 329
Study: 35982138

Group type: EXPERIMENTAL
Intervention: High emotion control (H‐EC) training condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low emotion control (L‐EC) training condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individuals with reported ADHD symptoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study: 33206131

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block with spinal morphine
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block
Number of subjects: 924